In our study, we found LTX-315 treatment could increase infiltration of CD8+ T cells and significantly decrease Tregs in the tumor bed, which altered the tumor microenvironment by turning “immune cold” tumors into “immune hot” tumors while improving the immunologically suppressive microenvironment. The gene discussed is CD8A; the disease is neoplasm.